January 18, 2024
COLUMBIA, Md. — Shimadzu Scientific Instruments introduces the ICPMS-2040/2050 series of inductively coupled plasma mass spectrometers that feature a proprietary advanced mini-torch system, a redesigned collision/reaction cell and a high-performance quadrupole mass filter with enhanced resolution. The ICPMS-2040/2050 series is ideal for analyzing the concentration of inorganic elements in solution samples in a wide range [...]
University of Bristol stem cell spinout secures £7.6m seed funding
January 18, 2024
CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of new stem cell therapies, has announced a £7.6 million seed round. The company aims to enable the cost-effective, reliable, and rapid development of new cell therapies. Stem cells unlock a range of treatment possibilities that have not previously been available to [...]
AcouSort extends collaboration with leading cell therapy company into a third project phase
January 18, 2024
AcouSort’s collaboration with the global life science company has reached yet another significant milestone with the signing of a Statement of Work (SoW) describing Phase 3 in the ongoing collaboration. The new assignment will generate revenues of at least SEK 485,000 in 2024. The collaboration, which began in 2022, aims to demonstrate how AcouSort’s AcouWash [...]
January 18, 2024
BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company’s protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer and distributor with a [...]
January 18, 2024
PhenoCycler®-Fusion system selected as the Centre’s platform technology for advanced spatial biology studies MARLBOROUGH, Mass. -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that the newly established Queensland Spatial Biology Centre (QSBC), located in Brisbane, Australia, is using the PhenoCycler-Fusion spatial biology platform as the core technology to revolutionize the way cancer and [...]
January 18, 2024
Novel GHz-class NMR systems are enabling unprecedented life science and materials research in functional structural biology, drug discovery, metabolomics and cleantech research. COLUMBUS, Ohio - Bruker Corporation, the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions for life and materials research, today announced the successful installation of a 1.2 Gigahertz (GHz) NMR system at [...]
January 18, 2024
This weekend LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning at the International Plant and Animal Genome conference (PAG) in San Diego. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes – from lysate to eluate – for both plant and animal samples. This magnetic [...]
iXCells Biotechnologies Strengthens Leadership Team; Welcomes New CEO
January 18, 2024
Helge Bastian, PhD, joins executive team as new CEO. SAN DIEGO -- iXCells Biotechnologies USA, Inc. ("iXCells"), a cell technology company specializing in providing cell-based products and drug discovery service solutions to the global academic, biotech, pharmaceutical, and rare disease communities, today announced the appointment of Helge Bastian, PhD, as the company’s new Chief Executive [...]
January 18, 2024
COLUMBIA, Md. — Shimadzu Scientific Instruments introduces the ICPMS-2040/2050 series of inductively coupled plasma mass spectrometers that feature a proprietary advanced mini-torch system, a redesigned collision/reaction cell and a high-performance quadrupole mass filter with enhanced resolution. The ICPMS-2040/2050 series is ideal for analyzing the concentration of inorganic elements in solution samples in a wide range of [...]
GeminiBio Appoints Steven Sandoval, Sr. to its Board of Directors
January 18, 2024
* Senior biopharma and cell therapy engineering/operations executive with 30+ years of experience to help drive growth FORT LAUDERDALE, Fla. and WEST SACRAMENTO, Calif. -- Gemini BioProducts Holding, Inc. ("GeminiBio" or the "Company"), a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Florida-based healthcare private equity firm, announced the appointment of Steven Sandoval, Sr., to its Board of [...]

